Use of diazoxide in the treatment of ischemia retinae
CA 2518676 C · Owner: Universite De Nice - Sophia Antipolis · Inventors: Ettaiche, Mohamed; Lazdunski, Michel
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the use of a composition comprising diazoxide (7-chloro-3-methyl-2H-1,2,4-benzothiadiazine-1,1-dioxide) for the production of a medicament for the treatment and/or prevention of ischemia retinae and diseases associated with an ischemia retinae. The composition used for the above may also contain riluzole or a derivative thereof with neuroprotective activity or a pharmaceutically-acceptable salt thereof.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 11, 2004 and granted July 17, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 11, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 11, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.